R
Renate Predl
Publications - 4
Citations - 946
Renate Predl is an academic researcher. The author has contributed to research in topics: Monoclonal antibody & Antibody. The author has an hindex of 3, co-authored 4 publications receiving 917 citations.
Papers
More filters
Journal ArticleDOI
Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization.
Andrea Buchacher,Renate Predl,K. Strutzenberger,Willibald Steinfellner,Alexandra Trkola,Martin Purtscher,Gerhard Gruber,Christopher Tauer,Franz Steindl,Alois Jungbauer,Hermann Katinger +10 more
TL;DR: Electrofusion turned out to be a more efficient immortalization method than EBV transformation, due to a high and constant immortalization rate, and the yield of stable specific hybridomas was increased twofold.
Journal ArticleDOI
A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1
Martin Purtscher,Alexandra Trkola,Gerhard Gruber,Andrea Buchacher,Renate Predl,Franz Steindl,Christa Tauer,Rudolf Berger,Noel Barrett,Alois Jungbauer,Hermann Katinger +10 more
TL;DR: A hybridoma clone, designated 2F5, secreting a neutralizing human monoclonal antibody specific for gp41 of human immunodeficiency virus type 1 (HIV-1) showed broad-spectrum neutralizing capacity against HIV-1 laboratory isolates IIIB, MN, RF, and SF2.
Patent
Monoclonal antibodies against hiv-1 and vaccines made thereof
Claudia Ballaun,Andrea Buchacher,Wolfgang Ernst,Hermann Katinger,Annelies Klima,Thomas Muster,Renate Predl,Martin Purtscher,C. Schmatz,Franz Steindl,Alexandra Trkola +10 more
TL;DR: In this article, the European Collection of Animal Cell Cultures (ECACC) at the PHLS in Porton Down, Salisbury, UK has been used to obtain human monoclonal antibodies that can be used for active and passive immunization of persons in need of such treatment.
Patent
Anticorps monoclonaux contre vih 1 et vaccins en decoulant
Hermann Katinger,Andrea Buchacher,Wolfgang Ernst,Claudia Ballaun,Martin Purtscher,Alexandra Trkola,Renate Predl,C. Schmatz,Annelies Klima,Franz Steindl,Thomas Muster +10 more
TL;DR: In this article, the present invention decrit des anticorps pouvant etre utilises pour la fabrication de vaccins pour une immunisation active et/ou passive de personnes ayant besoin d'un tel traitement.